Resveratrol is cytotoxic and acts synergistically with NF- κB inhibition in osteosarcoma MG-63 cells.
Conclusions: Our in vitro preclinical study in the MG-63 cell line model supports the translation of Res to the clinical management of patients with osteosarcoma.
PMID: 33488869 [PubMed]
Source: Archives of Medical Science - Category: Biomedical Science Tags: Arch Med Sci Source Type: research
More News: Biomedical Science | Bone Cancers | Cancer & Oncology | Chemotherapy | Osteosarcoma | Science | Statistics | Study | Toxicology